I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Background People with rare cancers often have limited treatment options. The biology of rare cancers is not well understood. Researchers want to find better treatments for these cancers. They want to test 2 drugs that, taken separately, have helped people with non-rare cancers. They want to see if these drugs …
neutrophil count
squamous cell carcinoma
lepidic predominant adenocarcinoma
nilotinib
carcinosarcoma
- 0 views
- 19 Feb, 2024